Voyager Therapeutics (VYGR) Net Cash Flow Growth (1y) (2015 - 2026)
Voyager Therapeutics (VYGR) Net Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 301.06% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - | -748.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -748.94% |
| Dec 31, 2025 | 142.03% |
| Sep 30, 2025 | -89.22% |
| Jun 30, 2025 | 53.97% |
| Mar 31, 2025 | -95.52% |
| Dec 31, 2024 | -1,264.96% |
| Sep 30, 2024 | 120.33% |
| Jun 30, 2024 | -179.55% |
| Mar 31, 2024 | -55.39% |
| Dec 31, 2023 | 68.32% |
| Sep 30, 2023 | -1,066.08% |
| Jun 30, 2023 | 55.49% |
| Mar 31, 2023 | 1,072.87% |
| Dec 31, 2022 | -64.77% |
| Sep 30, 2022 | 390.96% |
| Jun 30, 2022 | -119,673.33% |
| Mar 31, 2022 | 8.09% |
| Dec 31, 2021 | 113.85% |
| Sep 30, 2021 | -303.74% |
| Jun 30, 2021 | 100.22% |